Reply: Should BP targets be lower in diabetic patients with microalbuminuria or nephropathy?

Abstract

Get full access to this article

View all access options for this article.

References

Rossing P. , Tarnow L. , Boelskifte S. , Jensen BR , Nielsen FS , Parving HH Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment. Diabetes 1997 ;46:4817.

Sawicki PT , Berger M. Measuring progression of diabetic nephropathy. Review. Eur J Clin Invest 1994;24:651-5.

Estacio RO , Jeffers BW , Gifford N. , Schrier RW Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care 2000;23(Suppl 2):B54-B64.

SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.

Winocour PH Effective diabetes care: a need for realistic targets. BMJ 2002;324:1577-80.

Sawicki PT , Mühlhauser I. , Didjurgeit U. , Berger M. Improvement of hypertension care by a structured treatment and teaching programme . J Hum Hypertens 1993;7:10-14.

Trocha AK , Schmidtke C. , Didjurgeit U. et al. Intensified antihypertensive treatment in diabetic nephropathy: Mortality and morbidity results of a prospective controlled 10 years study . J Hypertens 1999;17:1497-503.